Keywords: fujisawa, 9-month, sales, rise, japanese, drugmaker, pharmaceuticals
Fujisawa's 9-month sales rise 2.5%
Article | 21 February 2005
Japanese drugmaker Fujisawa Pharmaceuticals has reported strong consolidated results for the first nine-month period of its financial year ending March 2005, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
